Ms. Hassan (for herself, Mr. Paul, Mr. Hickenlooper, and Mr. Lee) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Increasing Transparency in Generic Drug Applications Act. S. 1302. 119th
Cong., 1st
sess., Introduced in Senate April 3, 2025. https://www.govinfo.gov/app/details/BILLS-119s1302is.
APA
Congress, Senate (2025, April 3). Increasing Transparency in Generic Drug Applications Act (S. 1302 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s1302is.
MLA
United States, Congress, Senate. Increasing Transparency in Generic Drug Applications Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s1302is. 119th Congress, S. 1302, Introduced in Senate 3 Apr. 2025.
Bluebook
S.1302 - 119th Congress (2025-2026): Increasing Transparency in Generic Drug Applications Act, S.1302, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s1302is.
